세계의 말초동맥질환 시장 규모, 점유율, 동향 분석 : 제품 유형별, 최종사용자별, 지역별, 전망 및 예측(2024-2031년)

Global Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Regional Outlook and Forecast, 2024 - 2031

US $ 3,600 ￦ 4,956,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 5,947,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,326,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

말초동맥질환 시장 규모는 예측 기간 동안 6.9%의 CAGR로 성장하여 2031년까지 71억 달러에 달할 것으로 예상됩니다.

또한 의료기술의 급속한 발전으로 PAD 치료의 상황이 크게 바뀌면서 새로운 희망이 생겨났고, 환자들의 치료 결과도 개선되고 있습니다. 최소침습 수술 역시 기술 발전이 큰 영향을 미치는 분야입니다. 따라서 이러한 발전이 시장 성장을 주도하고 있습니다.

그러나 약물 용출 스텐트, 죽종 절제술용 장치, 최소침습 수술은 효과가 높지만, 많은 환자들에게 고가이기 때문에 접근하기 어려운 경우가 있습니다. 또한, 고급 PAD 치료에 따른 높은 비용은 혁신과 시장 성장을 저해할 수 있습니다. 따라서 고급 PAD 치료의 높은 비용은 시장 성장에 큰 장벽으로 작용하고 있습니다.

또한, COVID-19로 인한 경제 침체도 큰 문제를 야기했습니다. 많은 사람들이 실업과 소득 감소로 인해 경제적 어려움에 직면하여 의료비를 마련할 수 없게 되었습니다. 이미 많은 PAD 환자들에게 장벽이 되었던 높은 치료비는 팬데믹으로 인해 더 큰 부담을 안겨주었습니다. 의료 서비스 제공자들도 팬데믹 기간 동안 큰 어려움에 직면했습니다. 이처럼 팬데믹은 시장 전반에 걸쳐 부정적인 영향을 미쳤습니다.

제품 유형 전망

제품 유형에 따라 시장은 장치와 의약품으로 나뉩니다. 기기 부문은 2023년 시장에서 41%의 매출 점유율을 차지했습니다. 약물 치료만으로는 충분하지 않은 진행성 질환의 경우, 의료기기는 PAD의 진단, 개입 및 관리에 필수적입니다. 장치 부문에는 진단용 영상 도구, 혈관성형술용 풍선, 스텐트, 죽종절제술용 장치 등 다양한 제품이 포함됩니다.

최종사용자 전망

최종사용자를 기준으로 시장은 전문 클리닉과 병원으로 분류됩니다. 전문 클리닉 부문은 2023년 시장에서 45%의 매출 점유율을 기록했습니다. 전문 클리닉은 환자 중심의 접근 방식으로 유명하며 개인화 된 치료 계획과보다 면밀한 환자 모니터링을 제공합니다. 건강 결과의 개선은 개인화된 치료에 중점을 둔 결과이며, 환자 만족도와 치료 프로토콜에 대한 환자 순응도도 향상됩니다.

지역 전망

지역별로 보면 시장은 북미, 유럽, 아시아태평양, LAMEA에 걸쳐 분석되었습니다. 북미 부문은 2023년 시장에서 39%의 매출 점유율을 차지했습니다. 이 지역에는 당뇨병, 고혈압, 비만, 흡연과 같은 PAD 위험 요소의 높은 유병률과 같은 여러 가지 요인이 이러한 우위에 기여하고 있습니다.

목차

제1장 시장 범위와 조사 방법

• 시장 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요람

• 주요 하이라이트

제3장 시장 개요

• 소개
  • 개요
    • 시장 구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 과제
• Porter's Five Forces 분석

제4장 세계의 말초동맥질환 시장 : 제품 유형별

• 세계의 의약품 시장 : 지역별
• 세계의 말초동맥질환 시장 : 약 종류별
• 세계의 디바이스 시장 : 지역별
• 세계의 말초동맥질환 시장 : 디바이스 유형별

제5장 세계의 말초동맥질환 시장 : 최종사용자별

• 세계의 병원 시장 : 지역별
• 세계의 전문 클리닉 시장 : 지역별

제6장 세계의 말초동맥질환 시장 : 지역별

• 북미
  • 북미의 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽의 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양의 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카, 중동 및 아프리카
  • 라틴아메리카, 중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트
    • 사우디아라비아
    • 남아프리카공화국
    • 나이지리아
    • 기타 라틴아메리카, 중동 및 아프리카

제7장 기업 개요

• Becton, Dickinson, and Company
• Bayer AG
• Koninklijke Philips NV
• Abbott Laboratories
• Terumo Corporation
• B Braun Melsungen AG
• Medtronic PLC
• Boston Scientific Corporation
• Cardinal Health, Inc
• Biotronik SE & Co KG

제8장 말초동맥질환 시장의 성공 필수 조건

ksm

영문 목차

영문목차

The Global Peripheral Artery Disease Market size is expected to reach $7.1 billion by 2031, rising at a market growth of 6.9% CAGR during the forecast period.

Europe has a high prevalence of PAD risk factors, including an aging population, high rates of smoking, and increasing incidence of diabetes and hypertension. Europe's strong healthcare systems, particularly in countries like Germany, France, and the United Kingdom, contribute to the region's significant market share. Consequently, the European region would acquire nearly 30% of the total market share by 2031.

Parotid artery disease is a common cardiovascular disorder that frequently results in mobility challenges and discomfort. High blood pressure, or hypertension, is an additional significant risk factor for PAD. According to the World Health Organization (WHO), hypertension affects approximately 1.28 billion adults aged 30-79 years everywhere in the world. Hence, as the prevalence of PAD continues to rise, the demand for effective treatments and management strategies will drive market growth.

Additionally, the rapid advancements in medical technology are significantly transforming the landscape of PAD treatment, offering new hope and improved patient outcomes. Minimally invasive procedures are another area where technological advancements have profoundly impacted. Thus, such advancements are driving the growth of the market.

However, Drug-eluting stents, atherectomy devices, and minimally invasive procedures, while highly effective, come with substantial price tags that can be prohibitive for many patients. Furthermore, the high costs associated with advanced PAD treatments can stifle innovation and market growth. Hence, the high cost of advanced PAD treatments is a significant barrier to market growth.

Moreover, the economic downturn of the pandemic also posed significant challenges. Many individuals faced financial hardships due to job losses and reduced incomes, affecting their ability to afford medical care. High treatment costs, already a barrier for many PAD patients, became even more prohibitive during the pandemic. Healthcare providers also faced significant challenges during the pandemic. Thus, the pandemic had an overall negative impact on the market.

Product Type Outlook

Based on product type, the market is bifurcated into devices and drugs. The devices segment procured 41% revenue share in the market in 2023. In advanced cases where pharmaceutical treatments alone are insufficient, medical devices are essential for the diagnosis, intervention, and management of PAD. The devices segment includes various products such as diagnostic imaging tools, angioplasty balloons, stents, and atherectomy devices.

End User Outlook

On the basis of end user, the market is classified into specialty clinics and hospitals. The specialty clinics segment witnessed 45% revenue share in the market in 2023. Specialty clinics are known for their patient-centered approach, providing personalized care plans and closer patient monitoring. Improved health outcomes are the result of this emphasis on individualized treatment, which also increases patient satisfaction and patient adherence to treatment protocols.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 39% revenue share in the market in 2023. There are numerous factors that contribute to this dominance, including the high prevalence of PAD risk factors in the region, including diabetes, hypertension, obesity, and smoking.

List of Key Companies Profiled

• Becton, Dickinson and Company
• Bayer AG
• Koninklijke Philips N.V.
• Abbott Laboratories
• Terumo Corporation
• B. Braun Melsungen AG
• Medtronic PLC
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Biotronik SE & Co. KG

Global Peripheral Artery Disease Market Report Segmentation

By Product Type

• Drugs
  • Antiplatelet Medicines
  • Statins
  • Anti Hypertensive Medication
  • Others
• Devices
  • Peripheral Stents
  • Peripheral Angioplasty Balloons
  • Peripheral Catheters
  • Plaque Modification Devices
  • Inferior Vena Cava Filters
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories

By End User

• Hospitals
• Specialty Clinics

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Peripheral Artery Disease Market, by Product Type
  • 1.4.2 Global Peripheral Artery Disease Market, by End User
  • 1.4.3 Global Peripheral Artery Disease Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Peripheral Artery Disease Market by Product Type

• 4.1 Global Drugs Market by Region
• 4.2 Global Peripheral Artery Disease Market by Drugs Type
  • 4.2.1 Global Antiplatelet Medicines Market by Region
  • 4.2.2 Global Statins Market by Region
  • 4.2.3 Global Anti Hypertensive Medication Market by Region
  • 4.2.4 Global Others Market by Region
• 4.3 Global Devices Market by Region
• 4.4 Global Peripheral Artery Disease Market by Devices Type
  • 4.4.1 Global Peripheral Stents Market by Region
  • 4.4.2 Global Peripheral Angioplasty Balloons Market by Region
  • 4.4.3 Global Peripheral Catheters Market by Region
  • 4.4.4 Global Plaque Modification Devices Market by Region
  • 4.4.5 Global Inferior Vena Cava Filters Market by Region
  • 4.4.6 Global Hemodynamic Flow Alteration Devices Market by Region
  • 4.4.7 Global Peripheral Accessories Market by Region

Chapter 5. Global Peripheral Artery Disease Market by End User

• 5.1 Global Hospitals Market by Region
• 5.2 Global Specialty Clinics Market by Region

Chapter 6. Global Peripheral Artery Disease Market by Region

• 6.1 North America Peripheral Artery Disease Market
  • 6.1.1 North America Peripheral Artery Disease Market by Product Type
    • 6.1.1.1 North America Drugs Market by Region
    • 6.1.1.2 North America Peripheral Artery Disease Market by Drugs Type
      • 6.1.1.2.1 North America Antiplatelet Medicines Market by Country
      • 6.1.1.2.2 North America Statins Market by Country
      • 6.1.1.2.3 North America Anti Hypertensive Medication Market by Country
      • 6.1.1.2.4 North America Others Market by Country
    • 6.1.1.3 North America Devices Market by Region
    • 6.1.1.4 North America Peripheral Artery Disease Market by Devices Type
      • 6.1.1.4.1 North America Peripheral Stents Market by Country
      • 6.1.1.4.2 North America Peripheral Angioplasty Balloons Market by Country
      • 6.1.1.4.3 North America Peripheral Catheters Market by Country
      • 6.1.1.4.4 North America Plaque Modification Devices Market by Country
      • 6.1.1.4.5 North America Inferior Vena Cava Filters Market by Country
      • 6.1.1.4.6 North America Hemodynamic Flow Alteration Devices Market by Country
      • 6.1.1.4.7 North America Peripheral Accessories Market by Country
  • 6.1.2 North America Peripheral Artery Disease Market by End User
    • 6.1.2.1 North America Hospitals Market by Country
    • 6.1.2.2 North America Specialty Clinics Market by Country
  • 6.1.3 North America Peripheral Artery Disease Market by Country
    • 6.1.3.1 US Peripheral Artery Disease Market
      • 6.1.3.1.1 US Peripheral Artery Disease Market by Product Type
      • 6.1.3.1.2 US Peripheral Artery Disease Market by End User
    • 6.1.3.2 Canada Peripheral Artery Disease Market
      • 6.1.3.2.1 Canada Peripheral Artery Disease Market by Product Type
      • 6.1.3.2.2 Canada Peripheral Artery Disease Market by End User
    • 6.1.3.3 Mexico Peripheral Artery Disease Market
      • 6.1.3.3.1 Mexico Peripheral Artery Disease Market by Product Type
      • 6.1.3.3.2 Mexico Peripheral Artery Disease Market by End User
    • 6.1.3.4 Rest of North America Peripheral Artery Disease Market
      • 6.1.3.4.1 Rest of North America Peripheral Artery Disease Market by Product Type
      • 6.1.3.4.2 Rest of North America Peripheral Artery Disease Market by End User
• 6.2 Europe Peripheral Artery Disease Market
  • 6.2.1 Europe Peripheral Artery Disease Market by Product Type
    • 6.2.1.1 Europe Drugs Market by Country
    • 6.2.1.2 Europe Peripheral Artery Disease Market by Drugs Type
      • 6.2.1.2.1 Europe Antiplatelet Medicines Market by Country
      • 6.2.1.2.2 Europe Statins Market by Country
      • 6.2.1.2.3 Europe Anti Hypertensive Medication Market by Country
      • 6.2.1.2.4 Europe Others Market by Country
    • 6.2.1.3 Europe Devices Market by Country
    • 6.2.1.4 Europe Peripheral Artery Disease Market by Devices Type
      • 6.2.1.4.1 Europe Peripheral Stents Market by Country
      • 6.2.1.4.2 Europe Peripheral Angioplasty Balloons Market by Country
      • 6.2.1.4.3 Europe Peripheral Catheters Market by Country
      • 6.2.1.4.4 Europe Plaque Modification Devices Market by Country
      • 6.2.1.4.5 Europe Inferior Vena Cava Filters Market by Country
      • 6.2.1.4.6 Europe Hemodynamic Flow Alteration Devices Market by Country
      • 6.2.1.4.7 Europe Peripheral Accessories Market by Country
  • 6.2.2 Europe Peripheral Artery Disease Market by End User
    • 6.2.2.1 Europe Hospitals Market by Country
    • 6.2.2.2 Europe Specialty Clinics Market by Country
  • 6.2.3 Europe Peripheral Artery Disease Market by Country
    • 6.2.3.1 Germany Peripheral Artery Disease Market
      • 6.2.3.1.1 Germany Peripheral Artery Disease Market by Product Type
      • 6.2.3.1.2 Germany Peripheral Artery Disease Market by End User
    • 6.2.3.2 UK Peripheral Artery Disease Market
      • 6.2.3.2.1 UK Peripheral Artery Disease Market by Product Type
      • 6.2.3.2.2 UK Peripheral Artery Disease Market by End User
    • 6.2.3.3 France Peripheral Artery Disease Market
      • 6.2.3.3.1 France Peripheral Artery Disease Market by Product Type
      • 6.2.3.3.2 France Peripheral Artery Disease Market by End User
    • 6.2.3.4 Russia Peripheral Artery Disease Market
      • 6.2.3.4.1 Russia Peripheral Artery Disease Market by Product Type
      • 6.2.3.4.2 Russia Peripheral Artery Disease Market by End User
    • 6.2.3.5 Spain Peripheral Artery Disease Market
      • 6.2.3.5.1 Spain Peripheral Artery Disease Market by Product Type
      • 6.2.3.5.2 Spain Peripheral Artery Disease Market by End User
    • 6.2.3.6 Italy Peripheral Artery Disease Market
      • 6.2.3.6.1 Italy Peripheral Artery Disease Market by Product Type
      • 6.2.3.6.2 Italy Peripheral Artery Disease Market by End User
    • 6.2.3.7 Rest of Europe Peripheral Artery Disease Market
      • 6.2.3.7.1 Rest of Europe Peripheral Artery Disease Market by Product Type
      • 6.2.3.7.2 Rest of Europe Peripheral Artery Disease Market by End User
• 6.3 Asia Pacific Peripheral Artery Disease Market
  • 6.3.1 Asia Pacific Peripheral Artery Disease Market by Product Type
    • 6.3.1.1 Asia Pacific Drugs Market by Country
    • 6.3.1.2 Asia Pacific Peripheral Artery Disease Market by Drugs Type
      • 6.3.1.2.1 Asia Pacific Antiplatelet Medicines Market by Country
      • 6.3.1.2.2 Asia Pacific Statins Market by Country
      • 6.3.1.2.3 Asia Pacific Anti Hypertensive Medication Market by Country
      • 6.3.1.2.4 Asia Pacific Others Market by Country
    • 6.3.1.3 Asia Pacific Devices Market by Country
    • 6.3.1.4 Asia Pacific Peripheral Artery Disease Market by Devices Type
      • 6.3.1.4.1 Asia Pacific Peripheral Stents Market by Country
      • 6.3.1.4.2 Asia Pacific Peripheral Angioplasty Balloons Market by Country
      • 6.3.1.4.3 Asia Pacific Peripheral Catheters Market by Country
      • 6.3.1.4.4 Asia Pacific Plaque Modification Devices Market by Country
      • 6.3.1.4.5 Asia Pacific Inferior Vena Cava Filters Market by Country
      • 6.3.1.4.6 Asia Pacific Hemodynamic Flow Alteration Devices Market by Country
      • 6.3.1.4.7 Asia Pacific Peripheral Accessories Market by Country
  • 6.3.2 Asia Pacific Peripheral Artery Disease Market by End User
    • 6.3.2.1 Asia Pacific Hospitals Market by Country
    • 6.3.2.2 Asia Pacific Specialty Clinics Market by Country
  • 6.3.3 Asia Pacific Peripheral Artery Disease Market by Country
    • 6.3.3.1 China Peripheral Artery Disease Market
      • 6.3.3.1.1 China Peripheral Artery Disease Market by Product Type
      • 6.3.3.1.2 China Peripheral Artery Disease Market by End User
    • 6.3.3.2 Japan Peripheral Artery Disease Market
      • 6.3.3.2.1 Japan Peripheral Artery Disease Market by Product Type
      • 6.3.3.2.2 Japan Peripheral Artery Disease Market by End User
    • 6.3.3.3 India Peripheral Artery Disease Market
      • 6.3.3.3.1 India Peripheral Artery Disease Market by Product Type
      • 6.3.3.3.2 India Peripheral Artery Disease Market by End User
    • 6.3.3.4 South Korea Peripheral Artery Disease Market
      • 6.3.3.4.1 South Korea Peripheral Artery Disease Market by Product Type
      • 6.3.3.4.2 South Korea Peripheral Artery Disease Market by End User
    • 6.3.3.5 Singapore Peripheral Artery Disease Market
      • 6.3.3.5.1 Singapore Peripheral Artery Disease Market by Product Type
      • 6.3.3.5.2 Singapore Peripheral Artery Disease Market by End User
    • 6.3.3.6 Malaysia Peripheral Artery Disease Market
      • 6.3.3.6.1 Malaysia Peripheral Artery Disease Market by Product Type
      • 6.3.3.6.2 Malaysia Peripheral Artery Disease Market by End User
    • 6.3.3.7 Rest of Asia Pacific Peripheral Artery Disease Market
      • 6.3.3.7.1 Rest of Asia Pacific Peripheral Artery Disease Market by Product Type
      • 6.3.3.7.2 Rest of Asia Pacific Peripheral Artery Disease Market by End User
• 6.4 LAMEA Peripheral Artery Disease Market
  • 6.4.1 LAMEA Peripheral Artery Disease Market by Product Type
    • 6.4.1.1 LAMEA Drugs Market by Country
    • 6.4.1.2 LAMEA Peripheral Artery Disease Market by Drugs Type
      • 6.4.1.2.1 LAMEA Antiplatelet Medicines Market by Country
      • 6.4.1.2.2 LAMEA Statins Market by Country
      • 6.4.1.2.3 LAMEA Anti Hypertensive Medication Market by Country
      • 6.4.1.2.4 LAMEA Others Market by Country
    • 6.4.1.3 LAMEA Devices Market by Country
    • 6.4.1.4 LAMEA Peripheral Artery Disease Market by Devices Type
      • 6.4.1.4.1 LAMEA Peripheral Stents Market by Country
      • 6.4.1.4.2 LAMEA Peripheral Angioplasty Balloons Market by Country
      • 6.4.1.4.3 LAMEA Peripheral Catheters Market by Country
      • 6.4.1.4.4 LAMEA Plaque Modification Devices Market by Country
      • 6.4.1.4.5 LAMEA Inferior Vena Cava Filters Market by Country
      • 6.4.1.4.6 LAMEA Hemodynamic Flow Alteration Devices Market by Country
      • 6.4.1.4.7 LAMEA Peripheral Accessories Market by Country
  • 6.4.2 LAMEA Peripheral Artery Disease Market by End User
    • 6.4.2.1 LAMEA Hospitals Market by Country
    • 6.4.2.2 LAMEA Specialty Clinics Market by Country
  • 6.4.3 LAMEA Peripheral Artery Disease Market by Country
    • 6.4.3.1 Brazil Peripheral Artery Disease Market
      • 6.4.3.1.1 Brazil Peripheral Artery Disease Market by Product Type
      • 6.4.3.1.2 Brazil Peripheral Artery Disease Market by End User
    • 6.4.3.2 Argentina Peripheral Artery Disease Market
      • 6.4.3.2.1 Argentina Peripheral Artery Disease Market by Product Type
      • 6.4.3.2.2 Argentina Peripheral Artery Disease Market by End User
    • 6.4.3.3 UAE Peripheral Artery Disease Market
      • 6.4.3.3.1 UAE Peripheral Artery Disease Market by Product Type
      • 6.4.3.3.2 UAE Peripheral Artery Disease Market by End User
    • 6.4.3.4 Saudi Arabia Peripheral Artery Disease Market
      • 6.4.3.4.1 Saudi Arabia Peripheral Artery Disease Market by Product Type
      • 6.4.3.4.2 Saudi Arabia Peripheral Artery Disease Market by End User
    • 6.4.3.5 South Africa Peripheral Artery Disease Market
      • 6.4.3.5.1 South Africa Peripheral Artery Disease Market by Product Type
      • 6.4.3.5.2 South Africa Peripheral Artery Disease Market by End User
    • 6.4.3.6 Nigeria Peripheral Artery Disease Market
      • 6.4.3.6.1 Nigeria Peripheral Artery Disease Market by Product Type
      • 6.4.3.6.2 Nigeria Peripheral Artery Disease Market by End User
    • 6.4.3.7 Rest of LAMEA Peripheral Artery Disease Market
      • 6.4.3.7.1 Rest of LAMEA Peripheral Artery Disease Market by Product Type
      • 6.4.3.7.2 Rest of LAMEA Peripheral Artery Disease Market by End User

Chapter 7. Company Profiles

• 7.1 Becton, Dickinson, and Company
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expense
  • 7.1.5 SWOT Analysis
• 7.2 Bayer AG
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
  • 7.2.4 Research & Development Expense
  • 7.2.5 SWOT Analysis
• 7.3 Koninklijke Philips N.V.
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental and Regional Analysis
  • 7.3.4 Research & Development Expense
  • 7.3.5 Recent strategies and developments:
    • 7.3.5.1 Acquisition and Mergers:
  • 7.3.6 SWOT Analysis
• 7.4 Abbott Laboratories
  • 7.4.1 Company Overview
  • 7.4.2 Financial Analysis
  • 7.4.3 Segmental and Regional Analysis
  • 7.4.4 Research & Development Expense
  • 7.4.5 Recent strategies and developments:
    • 7.4.5.1 Acquisition and Mergers:
  • 7.4.6 SWOT Analysis
• 7.5 Terumo Corporation
  • 7.5.1 Company Overview
  • 7.5.2 Financial Analysis
  • 7.5.3 Segmental and Regional Analysis
  • 7.5.4 Research & Development Expenses
  • 7.5.5 Recent strategies and developments:
    • 7.5.5.1 Product Launches and Product Expansions:
  • 7.5.6 SWOT Analysis
• 7.6 B. Braun Melsungen AG
  • 7.6.1 Company Overview
  • 7.6.2 Financial Analysis
  • 7.6.3 Segmental and Regional Analysis
  • 7.6.4 Research & Development Expenses
  • 7.6.5 SWOT Analysis
• 7.7 Medtronic PLC
  • 7.7.1 Company overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Segmental and Regional Analysis
  • 7.7.4 Research & Development Expenses
  • 7.7.5 Recent strategies and developments:
    • 7.7.5.1 Acquisition and Mergers:
  • 7.7.6 SWOT Analysis
• 7.8 Boston Scientific Corporation
  • 7.8.1 Company Overview
  • 7.8.2 Financial Analysis
  • 7.8.3 Segmental and Regional Analysis
  • 7.8.4 Research & Development Expense
  • 7.8.5 Recent strategies and developments:
    • 7.8.5.1 Acquisition and Mergers:
  • 7.8.6 SWOT Analysis
• 7.9 Cardinal Health, Inc.
  • 7.9.1 Company Overview
  • 7.9.2 Financial Analysis
  • 7.9.3 Segmental and Regional Analysis
  • 7.9.4 SWOT Analysis
• 7.10. Biotronik SE & Co. KG
  • 7.10.1 Company Overview
  • 7.10.2 SWOT Analysis

Chapter 8. Winning Imperatives for Peripheral Artery Disease Market

관련자료